Search Results

1 - 10 of 189 items :

  • Pharmacy, other x
Clear All
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

.JCONREL.2017.11.049 18. S. M. Đorđević, A. Santrač, N. D. Cekić, B. D. Marković, B. Divović, T. M. Ilić, M. M. Savić and S. D. Savić, Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances, Int. J. Pharm. 533 (2017) 421–430; https://doi.org/10.1016/J.IJPHARM.2017.05.051 19. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today 18 (2013) 290–297; https

Open access
Antiproliferative and genotoxic potential of xanthen-3-one derivatives

. Laphookhieo, J. K. Syers, R. Kiattansakul and K. Chantrapromma, Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense, Chem. Pharm. Bull. 54 (2006) 745–747; https://doi.org/10.1248/cpb.54.745 7. Q. B. Han, N. Y. Yang, H. L. Tian, C. F. Qiao, J. Z. Song, D. C. Chang, S. L. Chen, K. Q. Luo and H. X. Xu, Xanthones with growth inhibition against HeLa cells from Garcinia xipshuanbannaensis, Phytochemistry 69 (2008) 2187–2192; https://doi.org/10.1016/j.phytochem.2008.05.019 8. S. L. Niu, Z. L. Li, F. Ji, G. Y. Liu, N. Zhao, X. Q. Liu

Open access
Screening of flavonoid aglycons’ metabolism mediated by the human liver cytochromes P450

, Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes, Food Chem. Toxicol. 46 (2008) 939–948; https://doi.org/10.1016/j.fct.2007.10.023 19. K. M. Atherton, E. Mutch and D. Ford, Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity, Biochem. Pharmacol. 72 (2006) 624–631; https://doi.org/10.1016/j.bcp.2006.05.015 20. H. Doostdar, M. D. Burke and R. T. Mayer, Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1

Open access
Branched PLGA derivatives with tailored drug delivery properties

REFERENCES 1. P. Gentile, V. Chiono, I. Carmagnola and P. V. Hatton, An overview of poly(lactic -co- glycolic) acid (PLGA)-based biomaterials for bone tissue engineering, Int. J. Mol. Sci. 15 (2014) 3640–3659; https://doi.org/10.3390/ijms15033640 2. D. J. Hines and D. L. Kaplan, Poly(lactic -co- glycolic) acid-controlled-release systems: experimental and modeling insights, Crit. Rev. Ther. Drug Carrier Syst . 30 (2013) 257–276; https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2013006475 3. H. K. Makadia and S. J. Siegel, Poly lactic

Open access
Phenolic compounds of Iris adriatica and their antimycobacterial effects

, Phenolic metabolite profiles and antioxidants assay of three Iridaceae medicinal plants for traditional Chinese medicine “She-gan” by on-line HPLC–DAD coupled with chemiluminescence (CL) and ESI-Q-TOF-MS/MS, J. Pharmaceut. Biomed. 98 (2014) 40–51. https://doi.org/10.1016/j.jpba.2014.05.008 5. S. H. Wani, B. A. Padder, T. Mokhdomi, J. I. Mir, H. A. Bhat, Q. P. Hassan and R. A. Qadri, Antiproliferative activity of methanolic extracts of different Iris plant species against A549 and Caco-2 cell lines, J. Pharmacogn. Phytochem. 6 (2017) 1034–1037. 6. F

Open access
Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan based microspheres

Deliv. Rev. (2018); https://doi.org/10.1016/j.addr.2018.02.007 4. Y.-K. Wu, N.-C. Cheng and C.-M. Cheng, Biofilms in chronic wounds: pathogenesis and diagnosis, Trends Biotechnol . 37 (2019) 505–517; https://doi.org/10.1016/j.tibtech.2018.10.011 5. R. J. Reiter, D.-X. Tan, L. Fuentes-Broto and M. Luciano, Chapter 8 – Melatonin: A multitasking molecule , Progress in Brain Res. 181 (2010) 127–151; https://doi.org/10.1016/S0079-6123(08)81008-4 6. R. Hardeland, A. T. Slominski, R. M. Slominski, R. J. Reiter, M. A. Zmijewski and R. Paus

Open access
Implementation of medication management services at the primary healthcare level – a pilot study

32. K. Lewin, Field Theory In Social Science; Selected Theoretical Papers (D. Cartwright, Ed.). Harper & Brothers Publisher New York, New York 1976. 33. C. Blanchard, M. Livet, C. Ward, L. Sorge, T. D. Sorensen and M. R. McClurg, The active implementation frameworks: A roadmap for advancing implementation of comprehensive medication management in primary care, Res. Social Adm. Pharm. 13 (2017) 922-929; https://doi.org/10.1016/j.sapharm.2017.05.006 34. M. Livet, C. Blanchard, T. D. Sorensen and M. R. McClurg, An implementation system for

Open access
Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study

. Clin. North. Am . 18 (2000) 625–636; https://doi.org/10.1016/S0733-8627(05)70150-4 34. C. Eiden, P. Cathala, N. Fabresse, Y. Galea, J. C. Mathieu-Daude, E. Baccino and E. H. Peyrière, A case of drug-facilitated sexual assault involving 3,4-methylenedioxy-methylamphetamine, J. Psychoactive Drugs 45 (2013) 94–97; https://doi.org/10.1080/02791072.2013.763573 35. A. L. van Nuijs, S. Castiglioni, I. Tarcomnicu, C. Postigo, M. Lopez de Alda, H. Neels, E. Zuccato, D. Barcelo and A. Covaci, Illicit drug consumption estimations derived from wastewater

Open access
Application of medicinal plants in several dermatovenerological entities

.28.3.985227 3. S. M. A. Middelkamp-Hup, J. D. Bos, F. Rius-Diaz, S. Gonzalez and W. Westerhof, Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study, J. Eur. Acad. Dermatol. Venereol . 21 (2007) 942–950; https://doi.org/10.1111/j.1468-3083.2006.02132.x 4. A. Pacifico, A. Vidolin, G. Leone and P. Iacovelli, Combined treatment of narrowband ultraviolet B light (NBUVB) phototherapy and oral Polypodium leucotomos extract versus NB UVB phototherapy alone in the treatment of

Open access
Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach

. Murthy and S. K. Panda, Development and validation of a stability-indicating RP–HPLC method for estimation of atazanavir sulfate in bulk, J. Pharm. Anal. 7 (2017) 134–140; https://doi.org/10.1016/j.jpha.2013.12.002 9. C. H. Bhirud and S. N. Hiremath, Stability indicating RP-HPLC method for the determination of atazanavir sulphate in bulk and dosage form, Drug Invent. Today 5 (2013) 81–86; https://doi.org/10.1016/j.dit.2013.05.008 10. L. Else, V. Watson, J. Tjia, A. Hughes, M. Siccardi, S. Khoo and D. Back, Validation of a rapid and sensitive high

Open access